The therapeutic field | Project name | Dosage form/specification | Category | Indications | Remark |
---|---|---|---|---|---|
Cardiovascular system | Reganosen | Injection/5ml: 0.4mg | Category 3 chemical drugs |
For diagnosis of myocardial ischemia |
Registered and available for raw material |
Landiolol hydrochloride | Injection (lyophilized)/50 mg | Category 3 chemical drugs |
For emergency treatment of arrhythmia |
Industrialized and available for raw material |
|
Bumetanide | Injection/0.5mg/ml Tablets/0.5mg, 1mg, 2mg |
Category 4 chemical drugs |
A diuretic used to treat edematous diseases. |
Industrialized and available for raw material |
|
Tolvaptan sodium phosphate | Injection (lyophilized)/8 mg, 16 mg | Category 4 chemical drugs |
It is used for fluid retention caused by heart failure with no obvious effect of other diuretics such as pan diuretics. |
Pilot study |
|
Ethyl eicosapentaenoate | Soft capsule/1G | Category 4 chemical drugs |
Used to reduce high triglycerides |
/ |
|
Omega-3-carboxylic acid ethyl ester | Soft capsule/1G | Category 4 chemical drugs |
Used to reduce high triglycerides |
/ |